Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study

Table 6 Stool frequency score for each IBS subtype (FAS)

IBS subtypes	Visit	N	Stool frequency score					95% CI of mean
IBS subtypes	Visit	N	Mean	SD	Minimum	Median	Maximum	95% CI of mean
IBS-C	Baseline	18	0.70	0.42	0.1	0.60	1.4	0.50, 0.90
	Week 2	18	0.91	0.40	0.3	0.90	2.0	0.71, 1.10
	Week 4	18	0.87	0.44	0.3	0.70	1.9	0.66, 1.09
IBS-D	Baseline	35	1.63	0.72	0.7	1.60	4.0	1.39, 1.88
	Week 2	33	1.64	0.72	0.4	1.60	4.1	1.39, 1.89
	Week 4	33	1.75	0.82	0.4	1.40	4.7	1.46, 2.04
IBS-M	Baseline	16	0.98	0.43	0.3	0.90	1.9	0.76, 1.21
	Week 2	16	1.11	0.37	0.6	1.00	1.9	0.92, 1.30
	Week 4	16	1.02	0.39	0.6	0.95	1.7	0.82, 1.22
Total	Baseline	69	1.24	0.72	0.1	1.10	4.0	1.07, 1.41
	Week 2	67	1.32	0.66	0.3	1.10	4.1	1.16, 1.47
	Week 4	67	1.34	0.76	0.3	1.30	4.7	1.16, 1.52

ISSN: 1751-0759